AGIOHealthcareBiotech — Hematology·Sep 3, 2026·1 min read

AGIO: FY25 Deep Dive

Agios Pharmaceuticals FY25 at $54M. NI $-413M; EPS $-7.12.

AGIO: FY25 Deep Dive

FY25 revenue $54M; OI $-472M; NI $-413M; EPS $-7.12.

Agios Pharmaceuticals FY25 (Dec 31, 2025) at $54M revenue. OpInc $-472M; NI $-413M; EPS $-7.12. Biotech — Hematology.

Related:AGIO

Want deeper analysis?

Ask drillr anything about AGIO — powered by SEC filings, earnings calls, and real-time data.

Try drillr.ai for free